Compare · HNGR vs HUM
HNGR vs HUM
Side-by-side comparison of Hanger Inc. (HNGR) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HNGR and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $42.74B, about 62.6x HNGR ($682.4M).
- HUM has hit the wire 4 times in the past 4 weeks while HNGR has been quiet.
- HUM has more recent analyst coverage (25 ratings vs 1 for HNGR).
- Company
- Hanger Inc.
- Humana Inc.
- Price
- $18.73+0.03%
- $359.17+0.92%
- Market cap
- $682.4M
- $42.74B
- 1M return
- -
- +31.06%
- 1Y return
- -
- +54.53%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2018
- News (4w)
- 0
- 4
- Recent ratings
- 1
- 25
Hanger Inc.
Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates through two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and provides payor network contracting services to other O&P providers. The Products & Services segment distributes O&P parts, componentry, and devices to independent O&P providers; and develops specialized rehabilitation technologies and provides evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of December 31, 2020, the company operated approximately 704 patient care clinics, and 112 satellite locations in 46 states and the District of Columbia. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest HNGR
- SEC Form SC 13G/A filed by Hanger Inc. (Amendment)
- SEC Form 15-12G filed by Hanger Inc.
- SEC Form EFFECT filed by Hanger Inc.
- SEC Form 4: Sullivan Kathryn M returned $1,162,988 worth of shares to the company (62,026 units at $18.75), closing all direct ownership in the company
- SEC Form 4: Jones Mark M returned $386,138 worth of shares to the company (20,594 units at $18.75), closing all direct ownership in the company
- SEC Form 4: Pettingill Richard returned $1,465,031 worth of shares to the company (78,135 units at $18.75), closing all direct ownership in the company
- SEC Form 4: Ahmad Asif returned $1,328,194 worth of shares to the company (70,837 units at $18.75), closing all direct ownership in the company
- SEC Form 4: Lucchese Cynthia L returned $1,272,206 worth of shares to the company (67,851 units at $18.75), closing all direct ownership in the company
- SEC Form 4: Begley Christopher B returned $1,432,762 worth of shares to the company (76,414 units at $18.75), closing all direct ownership in the company
- SEC Form 4: Hare Stephen E returned $2,006,419 worth of shares to the company (107,009 units at $18.75), closing all direct ownership in the company
Latest HUM
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
- Humana upgraded by Deutsche Bank with a new price target
- Humana Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness
- Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana
- Chief Financial Officer Mellet Celeste gave a grant of 15,387 units of Humana Common, decreasing direct ownership by 28% to 39,637 units (SEC Form 4)
- Chief Information Officer Mehta Japan was granted 9,448 units of Humana Common, increasing direct ownership by 122% to 17,176 units (SEC Form 4)
- President, Enterprise Growth Dintenfass David was granted 11,273 units of Humana Common, increasing direct ownership by 80% to 25,407 units (SEC Form 4)
- President & CEO Rechtin James A. was granted 35,633 units of Humana Common (SEC Form 4)